Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial is a research paper published in Neuro-Oncology Advances (2021). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: U01 NS093663
NINDS NIH HHS
Grant: U01 NS077352
NINDS NIH HHS
Grant: U24 NS107128
NINDS NIH HHS
Grant: U01 NS077179
NINDS NIH HHS
Grant: U24 NS107166
National Institute of Neurological Disorders and Stroke
FWCI
0.12
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals